Exicure Inc Total Liabilities
Exicure Inc total liabilities. Based on the latest financial reports, Exicure Inc (XCUR) has total liabilities worth $10.42 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Exicure Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Exicure Inc (2015–2025)
Total liabilities of Exicure Inc from 2015 to 2025. This chart illustrates how Exicure Inc's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Exicure Inc to see how much of total assets are deployed in long-term investments.
Exicure Inc Competitors by Total Liabilities
The table below lists competitors of Exicure Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pipe Works L. Girakian Profil S.A.
AT:PROFK
|
Greece | €22.94 Million |
|
Electroarges S
RO:ELGS
|
Romania | RON60.13 Million |
|
Kerlink SAS
PA:ALKLK
|
France | €16.45 Million |
|
Natural Alternatives International
NASDAQ:NAII
|
USA | $86.25 Million |
|
RWS Holdings PLC
LSE:RWS
|
UK | GBX277.70 Million |
|
Orange Minerals NL
AU:OMX
|
Australia | AU$623.65K |
|
Kore Mining Ltd
V:KORE
|
Canada | CA$3.25 Million |
|
Getty Images Holdings Inc.
NYSE:GETY
|
USA | $2.63 Billion |
Liability Composition Analysis (2015–2025)
This chart breaks down Exicure Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Exicure Inc assets under control.
Liquidity & Leverage Metrics
Exicure Inc Total Liabilities Ratios Explained
Exicure Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 10.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.91 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Exicure Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Exicure Inc (2015–2025)
The table below shows the annual total liabilities of Exicure Inc from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $10.12 Million | +22.10% |
| 2024-12-31 | $8.28 Million | -3.10% |
| 2023-12-31 | $8.55 Million | +1.70% |
| 2022-12-31 | $8.41 Million | -84.33% |
| 2021-12-31 | $53.64 Million | +37.75% |
| 2020-12-31 | $38.94 Million | +12.81% |
| 2019-12-31 | $34.52 Million | +342.29% |
| 2018-12-31 | $7.80 Million | -13.40% |
| 2017-12-31 | $9.01 Million | -50.29% |
| 2016-12-31 | $18.13 Million | +1203.24% |
| 2015-12-31 | $1.39 Million | -- |
About Exicure Inc
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood Ci… Read more